摘要
目的:探讨并确证匹诺塞林对脑缺血再灌注急性损伤的神经保护作用,进一步为匹诺塞林治疗缺血性脑卒中的临床应用提供依据。方法:SD大鼠50只,随机均分为假手术组、模型组、匹诺塞林1 mg/kg组、匹诺塞林3 mg/kg组、匹诺塞林10 mg/kg组,其中模型组及匹诺塞林各给药组采用大脑中动脉阻塞法(middle cerebral artery ocelusion,MCAO)建立脑缺血再灌注模型,分别与大脑中动脉阻塞2h再灌注同时给药,6h后取血并断头取脑,制作病理切片。HE染色观察额顶叶皮层(缺血半暗带)和纹状体病理变化,尼氏染色观察海马CA1区形态变化。酶联免疫吸附法(enzyme linked immunosorbent assay,ELISA)检测大鼠血清神经元特异性烯醇化酶(neuronal specific enolase,NSE)及S100-β蛋白水平。结果:匹诺塞林能够改善大鼠急性局灶性脑缺血再灌注的脑组织皮层、纹状体和海马神经元的形态,降低血清中NSE和S100-β蛋白的水平(P<0.05或P<0.01)。结论:匹诺塞林能减轻缺血再灌注造成的脑组织急性损伤,具有神经保护作用。
AIM:The aim of this work was to verify neuroprotective and properties of Pinocembrin,then provide a reference for further analysis of its mechanism on ischemic stroke.METHODS:The study was carried out on 50 male Sprague-Dawley rats,weighing 260- 300 g,which were divided into five groups:(i) control(n = 10),(ⅱ) I/R(n= 10),(ⅲ) I/R + Pinocembrin 1 mg/kg(n =10);(ⅳ) I/R + Pinocembrin 3 mg/kg(n = 10);(v) I/R + Pinocembrin 10 mg/kg(n = 10).Focal cerebral ischemia/reperfusion rats were induced by middle cerebral artery occlusion(MCAO) for 2 h followed by 6 h reperfusion.Pinocembrin was administered in doses 1 mg/kg,3 mg/kg,10 mg/kg respectively at the same time of onset of reperfusion.Then the blood NSE and S-100β were determined in addition to observe the pathological change of hippocampus,penumbra cortex,and corpus striatum respectively.RESULTS:Pinocembrin-treatment(3mg/kg or 10 mg/kg) significantly suppressed the levels of blood NSE and S-100β,and improved the morphology of brain cortex,striatum and hippocampus of acute focal cerebral ischemia reperfusion(10mg/kg).CONCLUSION:Pinocembrin has neuroprotective effects to prevent brain ischemia/reperfusion acute injury.
出处
《中国临床药理学与治疗学》
CAS
CSCD
2015年第11期1208-1211,1220,共5页
Chinese Journal of Clinical Pharmacology and Therapeutics
基金
山东省医药卫生科技发展计划项目(2014WS0119)